[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1794697A - 7-alkyl-pyrrolo{2,3-d}pyrimidines - Google Patents

7-alkyl-pyrrolo{2,3-d}pyrimidines

Info

Publication number
AU1794697A
AU1794697A AU17946/97A AU1794697A AU1794697A AU 1794697 A AU1794697 A AU 1794697A AU 17946/97 A AU17946/97 A AU 17946/97A AU 1794697 A AU1794697 A AU 1794697A AU 1794697 A AU1794697 A AU 1794697A
Authority
AU
Australia
Prior art keywords
pyrimidines
pyrrolo
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17946/97A
Inventor
Eva Altmann
Martin Missbach
Leo Widler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU1794697A publication Critical patent/AU1794697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU17946/97A 1996-03-06 1997-02-24 7-alkyl-pyrrolo{2,3-d}pyrimidines Abandoned AU1794697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810137 1996-03-06
EP96810137 1996-03-06
PCT/EP1997/000874 WO1997032879A1 (en) 1996-03-06 1997-02-24 7-ALKYL-PYRROLO[2,3-d]PYRIMIDINES

Publications (1)

Publication Number Publication Date
AU1794697A true AU1794697A (en) 1997-09-22

Family

ID=8225559

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17946/97A Abandoned AU1794697A (en) 1996-03-06 1997-02-24 7-alkyl-pyrrolo{2,3-d}pyrimidines

Country Status (2)

Country Link
AU (1) AU1794697A (en)
WO (1) WO1997032879A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753555B2 (en) * 1998-09-18 2002-10-24 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as protein kinase inhibitors

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704948D0 (en) 1997-03-11 1997-04-30 Knoll Ag Therapeutic agents
PT970084E (en) * 1997-03-19 2003-10-31 Abbott Gmbh & Co Kg PIRROLO¬2,3D | PYRIMIDINES AND THEIR USE AS TYROSIN KINASE INHIBITORS
US7863444B2 (en) 1997-03-19 2011-01-04 Abbott Laboratories 4-aminopyrrolopyrimidines as kinase inhibitors
PA8474101A1 (en) 1998-06-19 2000-09-29 Pfizer Prod Inc PYROLEUM [2,3-D] PIRIMIDINE COMPOUNDS
AU3951899A (en) 1998-06-19 2000-01-05 Pfizer Products Inc. Pyrrolo(2,3-d)pyrimidine compounds
US6713474B2 (en) 1998-09-18 2004-03-30 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as therapeutic agents
US7071199B1 (en) 1999-09-17 2006-07-04 Abbott Gmbh & Cco. Kg Kinase inhibitors as therapeutic agents
ES2208433T3 (en) 1999-12-10 2004-06-16 Pfizer Products Inc. PIRROLO COMPOUNDS (2,3-D) PYRIMIDINE AS PROTEIN KINASE INHIBITORS.
AU2000240570A1 (en) * 2000-03-29 2001-10-08 Knoll Gesellschaft Mit Beschraenkter Haftung Pyrrolopyrimidines as tyrosine kinase inhibitors
AP1911A (en) 2000-06-26 2008-10-30 Pfizer Prod Inc Pyrrolo[2,3-d]pyrimidine compounds.
US7301023B2 (en) 2001-05-31 2007-11-27 Pfizer Inc. Chiral salt resolution
US20040248906A1 (en) 2001-08-10 2004-12-09 Donato Nicholas J Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemia
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
NZ539901A (en) 2002-11-26 2007-09-28 Pfizer Prod Inc Method of treatment of transplant rejection
UA80171C2 (en) 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives
EP1730145A1 (en) * 2004-03-22 2006-12-13 Boehringer Ingelheim Pharmaceuticals Inc. Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
JP5147401B2 (en) * 2005-09-06 2013-02-20 塩野義製薬株式会社 Indolecarboxylic acid derivatives having PGD2 receptor antagonist activity
CN101389630A (en) 2005-12-29 2009-03-18 艾博特公司 Protein kinase inhibitors
KR20130012969A (en) 2007-11-01 2013-02-05 어큐셀라 인코포레이티드 Amine derivative compounds for treating ophthalmic diseases and disorders
MX2011001904A (en) 2008-08-20 2011-03-29 Pfizer Pyrrolo[2,3-d]pyrimidine compounds.
US8426428B2 (en) 2008-12-05 2013-04-23 Principia Biopharma, Inc. EGFR kinase knockdown via electrophilically enhanced inhibitors
BR112012005400A2 (en) 2009-09-10 2016-04-05 Irm Llc bicyclic heteroaryl ether type derivatives
JP2013512215A (en) 2009-11-25 2013-04-11 ノバルティス アーゲー Benzene condensed 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryl
CN102947275A (en) 2010-06-17 2013-02-27 诺瓦提斯公司 Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
JP2013528635A (en) 2010-06-17 2013-07-11 ノバルティス アーゲー Biphenyl-substituted 1,3-dihydro-benzimidazol-2-ylideneamine derivatives
WO2012120469A1 (en) 2011-03-08 2012-09-13 Novartis Ag Fluorophenyl bicyclic heteroaryl compounds
ES2740399T3 (en) 2011-03-09 2020-02-05 Richard G Pestell Prostate cancer cell lines, genetic signatures and uses of these
CA2873743C (en) 2012-05-14 2022-12-06 Prostagene, Llc Using modulators of ccr5 for treating cancer
US11920164B2 (en) 2014-07-30 2024-03-05 Yeda Research And Development Co. Ltd. Media for culturing naive human pluripotent stem cells
AU2017444054B2 (en) 2017-12-21 2021-10-07 Hefei Institutes Of Physical Science, Chinese Academy Of Sciences Class of pyrimidine derivative kinase inhibitors
EP3914698A1 (en) 2019-01-23 2021-12-01 Yeda Research and Development Co. Ltd Culture media for pluripotent stem cells
EP4058465A1 (en) 2019-11-14 2022-09-21 Cohbar Inc. Cxcr4 antagonist peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3036390A1 (en) * 1980-09-26 1982-05-13 Troponwerke GmbH & Co KG, 5000 Köln Antiinflammatory intermediate 7H-pyrrolo-(2,3-D)-pyrimidine derivs. - prepd. by dealkylation of 7-phenyl:ethyl derivs. by reaction with hydrochloric, phosphoric or poly:phosphoric acid
NO169490C (en) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRROLOPYRIMIDINE DERIVATIVES
DE69027862T2 (en) * 1989-09-19 1997-03-06 Teijin Ltd., Osaka PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES, METHOD FOR THE PRODUCTION AND MEDICINAL COMPOSITIONS CONTAINING THEM

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753555B2 (en) * 1998-09-18 2002-10-24 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as protein kinase inhibitors
AU753555C (en) * 1998-09-18 2003-07-03 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as protein kinase inhibitors

Also Published As

Publication number Publication date
WO1997032879A1 (en) 1997-09-12

Similar Documents

Publication Publication Date Title
AU1794697A (en) 7-alkyl-pyrrolo{2,3-d}pyrimidines
AU3176297A (en) Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
AUPN772396A0 (en) The kouris centri-turbine generator
AU2792197A (en) Microemulsion
AU1416195A (en) Substituted 1,2,3,4-tetrahydro-5-nitro pyrimidines
AU2894297A (en) 2,4-diaminopyrimidine derivatives
AU6123196A (en) N-aryl-1,2,4-triazolin-5-ones
ZA983177B (en) 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
AU3620297A (en) Substituted triazoloazinesulphonamides
AU7570296A (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
AU3771497A (en) Substituted p-trifluoromethylphenyluracils
AU1926397A (en) Substituted 1-methyl-3-benzyluracils
ZA982912B (en) 6,7-disubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
AUPP003297A0 (en) 4,5-diaryloxazole compounds
PL336265A1 (en) 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
AU1513597A (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
AU5692398A (en) Substituted 5-amino-1,3,4-thiadiazole-2-thiones
AU7073296A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidines
AU6904698A (en) Herbicidal 3,5-difluoropyridines
AU2955597A (en) Substituted phenyluracils
AU2137095A (en) Heterocyclyl-1,3,4-thiadiazolyloxyacetamides
AU1303897A (en) Herbicidal 1,2,4,6-thiatriazines
AU1655695A (en) 8-amino-pyrido (1,2,3-d,e)(1,3,4) benzoxadiazine derivatives
AU3500997A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidine derivatives